In the reply to the letter of concern from Shenzhen Stock Exchange, Guangzhou Ruoyuchen Technology Co.Ltd(003010) believed that the transdermal technology of sample beauty could be used in vaccination, insulin transdermal introduction and other fields, and also said that it would further deepen the business layout in the field of mass health consumption through this investment.
Benefiting from the positive news such as the rise of Internet e-commerce concept stocks, the stock price of Guangzhou Ruoyuchen Technology Co.Ltd(003010) has risen in eight trading days in the 12 trading days since May, including the daily limit in four trading days. Even if the attention letter from Shenzhen Stock Exchange was received due to the investment of 5 million yuan in a company with an annual loss of 1.39 million yuan, it did not stop the rise of Guangzhou Ruoyuchen Technology Co.Ltd(003010) and Guangzhou Ruoyuchen Technology Co.Ltd(003010) also ushered in its highest stock price in nearly a year – 23.5 yuan on May 11.
After another daily limit on May 18, Guangzhou Ruoyuchen Technology Co.Ltd(003010) replied to the attention letter of Shenzhen Stock Exchange, and the share price fell slightly the next day. As of the closing on May 20, Guangzhou Ruoyuchen Technology Co.Ltd(003010) closed at 21.12 yuan / share, up 0.09%, with a market value of about 2.6 billion yuan.
heavily invested medical beauty business company has not carried out medical beauty practice activities
On April 30, Guangzhou Ruoyuchen Technology Co.Ltd(003010) (hereinafter referred to as ” Guangzhou Ruoyuchen Technology Co.Ltd(003010) “) announced that Wuhu Guangzhou Ruoyuchen Technology Co.Ltd(003010) Investment Management Co., Ltd., a wholly-owned subsidiary, plans to invest 5 million yuan with Tianjin Guangzhou Ruoyuchen Technology Co.Ltd(003010) enterprise management consulting partnership (limited partnership) controlled by Wang Yu and Wang Wenhui, the actual controllers of the company, Subscribe for the newly increased registered capital of 7112400 yuan of sample beauty Biotechnology (Beijing) Co., Ltd. (hereinafter referred to as “sample beauty”), and hold 4.1597% equity of sample beauty respectively after the capital increase is completed.
Also disclosed is the financial data of Sampei in the last year. The operation of this company, which has invested millions of yuan, is not optimistic. According to the data, the revenue of sample beauty in 2021 was 1.695 million yuan and the net profit was 1.397 million yuan. In the first quarter of 2022, the revenue of sample beauty was only 49000 yuan, and the loss increased to 2.835 million yuan.
Guangzhou Ruoyuchen Technology Co.Ltd(003010) invested heavily in a loss making company. Not only did the investors not understand it, but the Shenzhen Stock Exchange also sent a concern letter asking Guangzhou Ruoyuchen Technology Co.Ltd(003010) to explain the necessity and rationality of investing in the same beauty as the related parties. After the extension to May 18, Guangzhou Ruoyuchen Technology Co.Ltd(003010) in the reply to the letter of concern of the Shenzhen Stock Exchange, said that the company and related parties invested in sample beauty because of the first mover advantages, product technology advantages and core team advantages of sample beauty.
The industry first mover advantage in Guangzhou Ruoyuchen Technology Co.Ltd(003010) analysis is not the medical beauty business advantage mentioned in the previous “announcement on joint investment and related party transactions with related parties”, but the industry advantage of small beauty appliances.
In addition, when replying whether sample beauty and its employees have relevant qualifications such as medical beauty services, Guangzhou Ruoyuchen Technology Co.Ltd(003010) said that according to the relevant provisions of the measures for the administration of medical beauty services (revised in 2016), Medical cosmetology refers to “the repair and reshaping of people’s appearance and various parts of the human body by using surgery, drugs, medical devices and other traumatic or invasive medical technical methods”, “beauty medical institutions must be registered by the administrative department of health and obtain the practice license of medical institutions before they can carry out practice activities”. Sample beauty’s main business is the R & D and sales of household water light import beauty instrument and supporting stock solution. It does not carry out the above-mentioned medical beauty practice activities and does not need to obtain the practice license of medical institution.
what kind of company is sample beauty
Tianyancha app shows that sample beauty was founded in 2017 and used to be called “Beijing willing beauty Technology Co., Ltd.” (hereinafter referred to as “willing beauty”). It is reported that the early wish beauty is a medical beauty e-commerce platform, which cuts into the medical beauty market with four sectors: beauty, medical beauty, luxury and community life. In September 2017 and December 2018, we obtained 10 million yuan of angel round financing and millions of yuan of angel round financing.
In February 2021, wish beauty was changed to sample beauty, and its business scope was also changed from the previous technology development and beauty to today’s drug Internet information service, medical device Internet information service, medical beauty service, life beauty service, class III medical device business, etc. In March 2022, Yangmei obtained a pre-A round of financing of tens of millions of yuan.
In the report on the pre-A round of financing of sample beauty, sample beauty aims at the middle zone between medical beauty and home beauty. On the one hand, it can replace the injection service items in medical beauty institutions – Shuiguang needle. On the other hand, the time-space Shuiguang instrument it has developed can replace traditional skin care products such as household water, lotion, face cream and essence, so as to realize the household use of medical beauty.
In the reply to the attention letter of the Shenzhen Stock Exchange of Guangzhou Ruoyuchen Technology Co.Ltd(003010) , sample beauty is a technology company focusing on the field of transdermal technology and integrating R & D, design, marketing and other capabilities. Its products are mainly composed of water light introduction beauty instrument and supporting stock solution. Sample beauty transdermal technology can also be used in vaccination, insulin transdermal delivery and other fields. It has broad application space and fully sees the development prospect of good sample beauty products and technology.
In addition to not carrying out medical beauty practice activities, Guangzhou Ruoyuchen Technology Co.Ltd(003010) also said that sample beauty did not independently produce the products sold, and the relevant products were purchased from a third party. There is no need to obtain special qualification and license for the research, development and sales of Shuiguang import beauty instrument and supporting stock solution. Among them, Shuiguang import beauty instrument belongs to personal care small household appliances. According to relevant laws and regulations, the sales of Shuiguang import beauty instrument by Yangmei is not included in the classification catalogue of medical devices, and there is no need to obtain business qualification such as medical device business license. From this point of view, the business involved in sample beauty is mainly the research and development and sales of medical beauty technology and skin care products.
big health consumption field into a new direction
Although the attribute of sample beauty’s medical beauty business remains to be discussed, in the reply to the letter of concern of Shenzhen Stock Exchange, Guangzhou Ruoyuchen Technology Co.Ltd(003010) believes that sample beauty’s transdermal technology can also be used in vaccine vaccination, insulin transdermal introduction and other fields, and also said that it will further deepen its business layout in the field of large-scale health consumption through this investment.
Guangzhou Ruoyuchen Technology Co.Ltd(003010) , which successfully landed on the Shenzhen Stock Exchange in September 2020, although it is called “the three swordsmen of the track operated by A-share e-commerce on behalf of Shanghai Lily&Beauty Cosmetics Co.Ltd(605136) , Hangzhou Onechance Tech Corp(300792) and others”, compared with the latter two, the volume of Guangzhou Ruoyuchen Technology Co.Ltd(003010) is slightly smaller. According to the data, in 2021, Guangzhou Ruoyuchen Technology Co.Ltd(003010) had a revenue of 1.288 billion yuan, a gross profit margin of 31.6% and a net profit of 29.2 million yuan Although the revenue of Hangzhou Onechance Tech Corp(300792) 1.135 billion yuan is slightly lower than Guangzhou Ruoyuchen Technology Co.Ltd(003010) , the gross profit margin is as high as 47.61% and the net profit is 330 million yuan Shanghai Lily&Beauty Cosmetics Co.Ltd(605136) has a revenue of 4.155 billion yuan, a gross profit margin of 36.46% and a net profit of 410 million yuan.
Compared with the single profit model of tmall and 010 , there are prominent problems such as dependence on and gross profit model . That is to say, Guangzhou Ruoyuchen Technology Co.Ltd(003010) the business of acting as a dealer for the brand contributes the most revenue to it, and its dependence on customers is too strong, which will lead to low bargaining power.
. It is reported that Guangzhou Ruoyuchen Technology Co.Ltd(003010) previously took the underwear washing track as the starting point to create a cutting-edge consumer brand “Kaijia”, which has achieved profitability in the first quarter of 2022.
Guangzhou Ruoyuchen Technology Co.Ltd(003010) in the business plan for 2021, it is pointed out that the company will pay attention to the personal care field and the layout of pet track under the large-scale health consumption. In the reply to the attention letter of Shenzhen Stock Exchange, Guangzhou Ruoyuchen Technology Co.Ltd(003010) also reiterated that in the future, the company will steadily expand beauty and skin care, pet food and other categories around the development idea of “science and technology + consumption”, so as to continuously improve the market influence of the company in the field of general health.
